Taiwan FDA registration cf2853d44c8b043f0a93495bfe9f1f83

Noludia glycohemoglobin reagent group

TW: 諾魯帝亞醣化血色素試劑組

Taiwan·Risk Class 2·SEKISUI MEDICAL CO., LTD. TSUKUBA PLANT·Registered May 21, 2010 – May 21, 2025Expired

Registration details

Analysis ID: cf2853d44c8b043f0a93495bfe9f1f83
Customs Code: DHA00602110800

Company information

Manufacturer: SEKISUI MEDICAL CO., LTD. TSUKUBA PLANT
Manufacturer Country: Japan
Authorized Representative: KUO'S YUAN IN ENTERPRISE CO., LTD.

Product details

Intended Use: Quantitative measurement of glycoglobin (Hemoglobin Alc) in whole blood.
Product Type (Level 1): B Hematology, pathology, and genetics
Product Type (Level 2): B.7470 Analysis of glycosylated hemoglobin
Import Information: import

Dates and status

Registration Date: May 21, 2010
Expiry Date: May 21, 2025

About this record

Access comprehensive regulatory information for Noludia glycohemoglobin reagent group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number cf2853d44c8b043f0a93495bfe9f1f83 and manufactured by SEKISUI MEDICAL CO., LTD. TSUKUBA PLANT. The authorized representative in Taiwan is KUO'S YUAN IN ENTERPRISE CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.